Adaptive Phage Therapeutics (APT) is a clinical-stage company. It provides therapeutic services for the treatment of antibiotic-resistant bacterial infections. APT’s approach consists of two components: PhageBank (a large and dynamically growing collection of bacteriophages) and a rapid system for matching phage to patient-specific bacterial infections.